Genix Pharmaceuticals Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GENPF research report →
About the company
Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in the Canadian market is on nutraceuticals and pharmaceuticals. Their product pipeline features several key developments: Flu-X: An herbal treatment available as an oral solution or spray, targeting viral infections, influenza, and coronaviruses responsible for common colds.
- CEO
- Sina Salehi Pirooz
- IPO
- 2020
- Employees
- 4,000
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $924.48K
- P/E
- -42.89
- P/S
- 0.00
- P/B
- -0.85
- EV/EBITDA
- -17.94
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 19.27%
- ROIC
- 14.86%
- Revenue
- $0 · -100.00%
- Net Income
- $-335,009 · -357.69%
- EPS
- $-0.01 · -366.67%
- Op Income
- $-153,262.3
- FCF YoY
- 33.78%
- 52W High
- $0.04
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 0.42
- Avg Volume
- 129
Get TickerSpark's AI analysis on GENPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GENPF coverage
Recent articles, reports, and earnings notes.
No research on GENPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GENPF report →Similar companies
Peers in the same neighborhood.